[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Article
April 1978

Pseudolymphoma in Renal Allograft Recipients

Author Affiliations

From the Section of Transplantation (Drs Geis, Iwatsuki, and Giacchino) Department of Surgery, and the Departments of Medicine (Drs Ing and Hano), Pathology (Dr Molnar), and Research (Dr Kerman), Loyola University-Stritch School of Medicine and Hines Veterans Administration Hospital, Maywood, Ill.

Arch Surg. 1978;113(4):461-466. doi:10.1001/archsurg.1978.01370160119020
Abstract

• Five renal transplant recipients exhibited giant systemic lymphadenopathy shortly after transplantation. Biopsy specimens did not show Hodgkin's lymphoma. Immunosuppression was continued in all patients. In contrast to the rapidly fatal course of malignant lymphoma in transplant recipients, adenopathy in these five patients has uniformly resolved. Patients have been observed for 6 to 15 months with no evidence of residual disease. Interval biopsy specimens are not malignant. Each patient received antithymocyte globulin from a single lot for 10 to 21 days after transplantation. During administration, T cell lymphocytes were suppressed to 5% of control values. When lymphadenopathy occurred, T cell values rebounded to 371% of control values. Toxoplasmosis titers as well as viral cultures of lymph node biopsy specimens were negative. These data indicate a benign course of this histologically malignant disease and suggest a lymphoblastic rebound phenomenon to antithymocyte globulin.

(Arch Surg 113:461-466, 1978)

References
1.
Penn I, Starzl TE:  Malignant tumors arising de novo in immunosuppressed organ transplant recipients . Transplantation 14:407-417, 1972.Article
2.
Hoover R, Fraumeni JF Jr:  Risk of cancer in renal transplant recipients . Lancet 2:55-57, 1973.Article
3.
Rappaport H:  Tumors of the hematopoietic system , in Atlas of Tumor Pathology . Washington, DC, Armed Forces Institute of Pathology, 1966, section 3, pt 8, pp 36-60.
4.
Berd D, Cornog J, DeConti RC, et al:  Long-term remission in diffuse histiocytic lymphoma treated with combination sequential chemotherapy . Cancer 35:1050-1054, 1975.Article
5.
DeVita VT Jr, Canellos GP, Chabner B, et al:  Advanced diffuse histiocytic lymphoma, a potentially curable disease: Results with combination chemotherapy . Lancet 1:248-250, 1975.Article
6.
Kerman RH, Geis WP:  Total and active T-cell dynamics in renal allograft recipients . Surgery 79:398-407, 1976.
7.
Iwatsuki S, Geis WP, Molnar Z, et al: Systemic lymphoblastic response to antithymocyte globulin in renal allograft recipients: An initial report. J Surg Res, to be published.
8.
Carbone PP, Kaplan HS, Masshoff K, et al:  Report of the committee on Hodgkin's disease staging classification . Cancer Res 31:1860-1861, 1971.
9.
Hertel BF, Matas AJ, Dehner LP, et al: Lymphoproliferative disorders in organ transplant recipients. Transplantation, to be published.
10.
Jones SE, Fuks Z, Bull M, et al:  Non-Hodgkin's lymphomas: IV. Clinicopathologic correlation in 405 cases . Cancer 31:806-823, 1973.Article
11.
Goffinett DR, Castellino RA, Kim H, et al:  Staging laparotomies in unselected patients with non-Hodgkin's lymphomas . Cancer 32:672-681, 1973.Article
12.
Chabner BA, Johnson RE, Chretien PB, et al:  Sequential nonsurgical and surgical staging of non-Hodgkin's lymphoma . Ann Intern Med 85:149-154, 1976.Article
13.
Jones SE, Rosenberg SA, Kaplan H, et al:  Non-Hodgkin's lymphomas, II. Single agent chemotherapy . Cancer 30:31-38, 1972.Article
14.
Matas AJ, Simmons RL, Najarian JS:  Chronic antigenic stimulation, herpesvirus infection, and cancer in transplant recipients . Lancet 1:1277-1279, 1975.Article
15.
Epstein MA, Achong BG, Barr YM:  Virus particles in cultured lymphoblasts from Burkitt's lymphoma . Lancet 1:702-703, 1964.Article
16.
Walford RC:  Increased incidence of lymphoma after injection of mice with cells different at weak histocompatibility loci . Science 152:78-80, 1966.Article
17.
Lukes RJ,  Tindle BH: Immunoblastic lymphadenopathy: A hyperimmune entity resembling Hodgkin's disease . N Engl J Med 292:1-8, 1975.Article
×